The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib, a second-generation bruton tyrosine kinase (Btk) inhibitor, in previously untreated chronic lymphocytic leukemia (CLL).
 
John C. Byrd
Research Funding - Acerta Pharma; Genentech; Pharmacyclics
 
Jeffrey Alan Jones
Consulting or Advisory Role - Genentech/Abbvie; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); MedImmune (Inst); Pharmacyclics (Inst)
 
Richard R. Furman
Honoraria - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
Consulting or Advisory Role - Genentech/Roche; Gilead Sciences; Janssen Biotech; Pharmacyclics
Speakers' Bureau - Genentech; Janssen; Pharmacyclics
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
 
Deborah Marie Stephens
No Relationships to Disclose
 
Steve Devereux
No Relationships to Disclose
 
Jennifer R. Brown
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; ProNAi; Roche/Genentech; Sun Pharma
 
Peter Hillmen
No Relationships to Disclose
 
Ahmed M. Hamdy
Employment - Acerta Pharma
Leadership - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
 
Maria Fardis
Employment - Acerta Pharma
Leadership - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
 
Manal Tawashi
Employment - Acerta Pharma
 
Min Hui Wang
Employment - Acerta Pharma
 
Priti Patel
Employment - Acerta Pharma
 
Diana Mittag
Employment - Acerta Pharma
 
Fanny Krantz
Employment - Acerta Pharma
 
Wayne Rothbaum
Employment - Acerta Pharma
 
Raquel Izumi
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Consulting or Advisory Role - Trigemina
Patents, Royalties, Other Intellectual Property - Patents pending for Acerta Pharma
 
Susan Mary O'Brien
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen; Pfizer; Pharmacyclics; ProNAi; Regeneron
Consulting or Advisory Role - Amgen; Celgene; CLL Global Research Foundation
Research Funding - Acerta Pharma; Gilead Sciences; Regeneron
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Regeneron
 
William G. Wierda
No Relationships to Disclose